Mr. Mucus gets a new home

Share this article:

Mr. Mucus is going to work for Reckitt Benckiser, which bought Adams Respiratory Therapeutics, maker of the heavily advertised Mucinex franchise, for $2.3 billion. Though better known for its household cleaning products, Reckitt makes opiate dependency treatment Suboxone and recently bought two OTC meds from Boots. 

Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.